|
Analogs
Draw
Identity
99%
90%
80%
70%
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.45 |
Binding ≤ 10μM
|
FYN-1-E |
Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
378 |
0.37 |
Binding ≤ 10μM
|
KC1A-1-E |
Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1D-1-E |
Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1E-1-E |
Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1G1-1-E |
Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1G2-1-E |
Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.30 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
100 |
0.41 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
45 |
0.43 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.49 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
185 |
0.39 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.32 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.32 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.32 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.50 |
Functional ≤ 10μM
|
Z100490-1-O |
ASPC1 (Pancreatic Tumour Cell Line) (cluster #1 Of 1), Other |
Other |
592 |
0.36 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
7 |
0.48 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
17 |
0.45 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
27 |
0.44 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
32 |
0.44 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
10 |
0.47 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
4870 |
0.31 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
9 |
0.47 |
Functional ≤ 10μM
|
ChEMBL Target Annotations
Uniprot |
Swissprot |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PGFRA_HUMAN |
P16234
|
Platelet-derived Growth Factor Receptor Alpha, Human |
45 |
0.43 |
Binding ≤ 1μM
|
PGFRB_HUMAN |
P09619
|
Platelet-derived Growth Factor Receptor Beta, Human |
4.2 |
0.49 |
Binding ≤ 1μM
|
ABL1_HUMAN |
P00519
|
Tyrosine-protein Kinase ABL, Human |
22 |
0.45 |
Binding ≤ 1μM
|
FYN_HUMAN |
P06241
|
Tyrosine-protein Kinase FYN, Human |
378 |
0.37 |
Binding ≤ 1μM
|
LCK_HUMAN |
P06239
|
Tyrosine-protein Kinase LCK, Human |
100 |
0.41 |
Binding ≤ 1μM
|
SRC_HUMAN |
P12931
|
Tyrosine-protein Kinase SRC, Human |
185 |
0.39 |
Binding ≤ 1μM
|
KC1A_HUMAN |
P48729
|
Casein Kinase I Alpha, Human |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1D_HUMAN |
P48730
|
Casein Kinase I Delta, Human |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1E_HUMAN |
P49674
|
Casein Kinase I Epsilon, Human |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1G1_HUMAN |
Q9HCP0
|
Casein Kinase I Gamma 1, Human |
7200 |
0.30 |
Binding ≤ 10μM
|
KC1G2_HUMAN |
P78368
|
Casein Kinase I Gamma 2, Human |
7200 |
0.30 |
Binding ≤ 10μM
|
PGFRA_HUMAN |
P16234
|
Platelet-derived Growth Factor Receptor Alpha, Human |
45 |
0.43 |
Binding ≤ 10μM
|
PGFRB_HUMAN |
P09619
|
Platelet-derived Growth Factor Receptor Beta, Human |
4.2 |
0.49 |
Binding ≤ 10μM
|
ABL1_HUMAN |
P00519
|
Tyrosine-protein Kinase ABL, Human |
22 |
0.45 |
Binding ≤ 10μM
|
FYN_HUMAN |
P06241
|
Tyrosine-protein Kinase FYN, Human |
378 |
0.37 |
Binding ≤ 10μM
|
LCK_HUMAN |
P06239
|
Tyrosine-protein Kinase LCK, Human |
100 |
0.41 |
Binding ≤ 10μM
|
SRC_HUMAN |
P12931
|
Tyrosine-protein Kinase SRC, Human |
185 |
0.39 |
Binding ≤ 10μM
|
VGFR1_HUMAN |
P17948
|
Vascular Endothelial Growth Factor Receptor 1, Human |
3100 |
0.32 |
Binding ≤ 10μM
|
VGFR2_HUMAN |
P35968
|
Vascular Endothelial Growth Factor Receptor 2, Human |
3100 |
0.32 |
Binding ≤ 10μM
|
VGFR3_HUMAN |
P35916
|
Vascular Endothelial Growth Factor Receptor 3, Human |
3100 |
0.32 |
Binding ≤ 10μM
|
Z80018 |
Z80018
|
A-375 (Malignant Melanoma Cells) |
7 |
0.48 |
Functional ≤ 10μM
|
Z100490 |
Z100490
|
ASPC1 (Pancreatic Tumour Cell Line) |
592 |
0.36 |
Functional ≤ 10μM
|
Z81057 |
Z81057
|
HUVEC (Umbilical Vein Endothelial Cells) |
4870 |
0.31 |
Functional ≤ 10μM
|
Z81170 |
Z81170
|
LNCaP (Prostate Carcinoma) |
9 |
0.47 |
Functional ≤ 10μM
|
Z80211 |
Z80211
|
LoVo (Colon Adenocarcinoma Cells) |
17 |
0.45 |
Functional ≤ 10μM
|
Z81024 |
Z81024
|
NCI-H460 (Non-small Cell Lung Carcinoma) |
10 |
0.47 |
Functional ≤ 10μM
|
Z80390 |
Z80390
|
PC-3 (Prostate Carcinoma Cells) |
27 |
0.44 |
Functional ≤ 10μM
|
PGFRB_HUMAN |
P09619
|
Platelet-derived Growth Factor Receptor Beta, Human |
3 |
0.50 |
Functional ≤ 10μM
|
Z80712 |
Z80712
|
T47D (Breast Carcinoma Cells) |
32 |
0.44 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.95 |
7.83 |
-10.84 |
2 |
5 |
0 |
59 |
325.343 |
4 |
↓
|
Ref
Reference (pH 7)
|
3.95 |
7.96 |
-9.94 |
2 |
5 |
0 |
59 |
325.343 |
4 |
↓
|
Lo
Low (pH 4.5-6)
|
3.95 |
7.89 |
-35.59 |
3 |
5 |
1 |
60 |
326.351 |
4 |
↓
|
|